This is the authors' abstract. We don't add key points for this paper.
Active surveillance (AS) is increasingly recognized as an appropriate strategy for selected patients with papillary thyroid microcarcinomas (PTMC). However, some factors, including physician-related ones, hinder its widespread adoption.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Duarte et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: